.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Colorcon
US Army
McKesson
Dow
Fuji
Chubb
Cerilliant
Daiichi Sankyo
Chinese Patent Office

Generated: November 18, 2017

San Marino Drug Patents

These international patent data are derived from patent families, based on US drug-patent linkages.
They should not be regarded as comprehensive records of ex-US drug-patent associations.

Document Number Estimated Expiration Equivalent US Patent US Expiry Date Generic Name US Applicant US Tradename
T201600452► Subscribe9636407Dec 21, 2032
caspofungin acetate
Fresenius Kabi Usa
CASPOFUNGIN ACETATE
T201600470► Subscribe9296782Jul 17, 2034
sofosbuvir; velpatasvir; voxilaprevir
Gilead Sciences Inc
VOSEVI
T201500126► Subscribe9439900Sep 18, 2032
buprenorphine hydrochloride; naloxone hydrochloride
Orexo Us Inc
ZUBSOLV
T201500126► Subscribe9259421Sep 18, 2032
buprenorphine hydrochloride; naloxone hydrochloride
Orexo Us Inc
ZUBSOLV
T201500126► Subscribe8940330Sep 18, 2032
buprenorphine hydrochloride; naloxone hydrochloride
Orexo Us Inc
ZUBSOLV
T201600476► Subscribe9296769Aug 15, 2032
emtricitabine; tenofovir alafenamide fumarate
Gilead Sciences Inc
DESCOVY
T201600476► Subscribe9296769Aug 15, 2032
emtricitabine; rilpivirine hydrochloride; tenofovir alafenamide fumarate
Gilead Sciences Inc
ODEFSEY
T201600476► Subscribe9296769Aug 15, 2032
cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate
Gilead Sciences Inc
GENVOYA
T201600476► Subscribe9296769Aug 15, 2032
tenofovir alafenamide fumarate
Gilead Sciences Inc
VEMLIDY
T201600476► Subscribe8754065Aug 15, 2032
emtricitabine; tenofovir alafenamide fumarate
Gilead Sciences Inc
DESCOVY
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
QuintilesIMS
Queensland Health
Deloitte
Cerilliant
Express Scripts
Covington
Mallinckrodt
Chubb
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot